Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in Nuffield Department of Clinical Neurosciences have found that a simple test carried out on a smartphone can help to predict future change in people in the early stages of Parkinson’s.

This study, supported by the NIHR Oxford Biomedical Research Centre (BRC) and funded by the Monument Trust Discovery Award from Parkinson's UK, has the potential to foster a more personalised approach to the treatment of Parkinson’s and allow clinicians to target interventions to those individuals most likely to benefit.

The smartphone test guides users through seven tasks assessing voice, balance, walking, reaction time, finger tapping, rest tremor and postural tremor.

The test, which takes around seven minutes in total to perform, makes use of the sensors in smartphones to measure different kinds of movement consistently and accurately.

Read more (Nuffield Department of Clinical Neurosciences website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.